|
09-17-2010, 01:48 AM
|
|||
|
|||
Experimental Drug Shows Promise for Bone Marrow Disorder
WEDNESDAY, Sept. 15 (HealthDay News) -- In ongoing early stage research, an experimental drug appears to go some distance toward reducing the tell-tale inflammatory impact of the deadly bone marrow disorder known as myelofibrosis.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Novartis's Experimental Drug Shows Promise in Cushing's Disease in Study | cancerfr | Pituitary Tumor | 0 | 09-22-2010 07:11 PM |
| Experimental Drug Shows Promise for Bone Marrow Disorder | cancerfr | Bone Cancer | 0 | 09-19-2010 04:01 AM |
| Incyte Drug for Bone Marrow Disorder, Licensed by Novartis, Eases Symptoms | cancerfr | Bone Cancer | 0 | 09-17-2010 01:48 AM |
| Doctors use bone marrow stem cells to treat skin disorder | cancerfr | Bone Cancer | 0 | 08-13-2010 03:59 AM |
| Experimental Lung Cancer Drug Shows Promise | cancerfr | Lung Cancer | 0 | 06-05-2010 05:17 PM |
Linear Mode
